glutathione pathway to triple negative cancer The crosstalk between metabolism and non-coding RNAs in progression and treatment resistance Ferroptosis heterogeneity in triple-negative breast
Ferroptosis heterogeneity in triple negative breast cancer reveals an innovative immunotherapy combination strategy ScienceDirect Metabolic reprogramming in triple negative breast cancer PMC GPX4 in triple negative breast cancer: A key regulator of ferroptosis and therapeutic target ScienceDirect NRF2 activation by cysteine as a survival mechanism for triple negative breast cancer cells Oncogene Unraveling the Potential Role of Glutathione in Multiple Forms of Cell Death in Cancer Therapy Lv 2019 Oxidative Medicine and Cellular Longevity Wiley Online Library Glutathione depletion and dihydroorotate dehydrogenase inhibition actuated ferroptosis augment to surmount triple negative breast cancer ScienceDirect
Pay in 4 interest-free payments of $6.47 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20





